TP53 and neoplasm: In tumours maintaining functional wild-type p53 (p53wt), chemotherapy often drives a senescence phenotype that has been shown to limit the clinical outcome when compared to the typical apoptotic response observed in mutant p53 (p53mut) tumours [9,10,11].